Blood Res 2020; 55(1):
Published online March 31, 2020
https://doi.org/10.5045/br.2020.55.1.68
© The Korean Society of Hematology
Correspondence to : Ik-Chan Song
Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, Chungnam National University, 266 Munhwa-ro, Daejeon 35015, Korea
E-mail: petrosong@naver.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thank you for your interests in our observations and good suggestions. Thromboembolism can precede overt presentation of a myeloproliferative neoplasm (MPN) by a few years. In this context, your suggestions on the molecular testing in stroke patients may be reasonable. Mayo Clinic has screened
No potential conflicts of interest relevant to this article were reported.
Blood Res 2020; 55(1): 68-68
Published online March 31, 2020 https://doi.org/10.5045/br.2020.55.1.68
Copyright © The Korean Society of Hematology.
Ik-Chan Song
Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea
Correspondence to:Ik-Chan Song
Division of Hematology/Oncology, Department of Internal Medicine, College of Medicine, Chungnam National University, 266 Munhwa-ro, Daejeon 35015, Korea
E-mail: petrosong@naver.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thank you for your interests in our observations and good suggestions. Thromboembolism can precede overt presentation of a myeloproliferative neoplasm (MPN) by a few years. In this context, your suggestions on the molecular testing in stroke patients may be reasonable. Mayo Clinic has screened
No potential conflicts of interest relevant to this article were reported.